Intended Use

The Philips Lumify Diagnostic Ultrasound System is intended for diagnostic ultrasound imaging and fluid flow analysis in fetal/obstetric, abdominal, pediatric, cephalic, urology, gynecological, cardiac fetal echo, small organ, musculoskeletal, peripheral vessel, carotid, cardiac, and lung applications.

Technology

The system uses a commercial off-the-shelf Android or iOS device coupled with Philips Lumify software and a variety of ultrasound transducers to acquire ultrasound data. The AI Auto EF Quantification feature is based on the LVivo EF algorithm and provides automated measurement of left ventricular ejection fraction, end diastolic volume, and end systolic volume from apical four-chamber views, including automatic tracing and tracking of left ventricle borders with editing and error rejection capabilities.

Performance

Non-clinical verification testing including functional testing, risk analysis, and design reviews were conducted to ensure safe and effective performance of the software change with the Auto EF feature. A clinical performance study using 80 patients showed strong correlation (r=0.82 for EF) between automated AI measurements and manual tracing by sonographers, with 95% successful clip processing. There was no clinical investigation needed beyond this study.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    8/17/2023

    2 months
  • 2

    FDA Approval

    10/26/2023

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.